tirzepatide available in pill form Oral Pill: FDA-Approved Options hormone GLP FDA Approves Eli Lilly's Obesity
Description
But its getting more attention because some people on GLP-1 drugs developed the condition

Nausea, diarrhea, vomiting, and constipation commonly occur within the first month of starting.[ref][ref] Note that for many people, gastrointestinal side effects seem to be dose-related

If theres something we missed or something we could improve on, wed love to hear it
Understanding how to maintain weight loss after tirzepatide requires a comprehensive strategy that some patients can implement with lower maintenance doses or careful weaning protocols

With the approval of tirzepatide for weight loss, the use of this drug saw a rapid rise
